ada guidelines dpp4 and glp 1 Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1 GLP-1-RA and DPP-4 inhibitors in
Description
If your BMI is 27 or over, you may qualify if you have prediabetes (with a blood sugar A1C level of 5.7 to 6.4), a history of heart attack or stroke, or blocked leg arteries that cause symptoms
instead, we work closely with our members to encourage lifestyle changes that promote lasting results
Protocol 2: Companion to GLP-1 medication Goal: Reduce GLP-1 medication side effects and support gut health during treatment
Mounjaro uses a different ingredient, tirzepatide, which targets both GLP-1 and GIP hormones, potentially offering additional benefits for weight loss and diabetes control
Gaspari T, Liu H, Welungoda I, Hu Y, Widdop RE, Knudsen LB, Simpson RW, Dear AE
